insurance coverage of glp 1 GLP-1 Weight Loss Drugs: Under Medicaid and Other Health Plans GLP-1 Medication: Understanding Your Options
Description
Abstract Currently, there is no disease-modifying treatment available for Alzheimers and Parkinsons disease (AD and PD) and that includes the highly controversial approval of the A-targeting antibody aducanumab for the treatment of AD
95% CI 1.67, 2.97
doi: 10.3389/fcell.2020.608388
A recent phase III trial testing exendin-4 did not show an improvement, which may be linked to the lack of insulin desensitization in the study participants
While exact gains vary, the consensus supports adding strength sessions two to three times per week for optimal muscle retention
